Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | -9.68% | -12.50% | -20.00% |
May. 03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
May. 03 | Ondine Biomedical to Raise GBP3 Million Via Placing, Subscription | MT |
Sales 2023 * | 1.18M 868K | Sales 2024 * | 2.6M 1.9M | Capitalization | 33.69M 24.71M |
---|---|---|---|---|---|
Net income 2023 * | -15M -11M | Net income 2024 * | -18M -13.2M | EV / Sales 2023 * | 27.5 x |
Net cash position 2023 * | 1.1M 807K | Net cash position 2024 * | 3.8M 2.79M | EV / Sales 2024 * | 11.5 x |
P/E ratio 2023 * |
-1.49
x | P/E ratio 2024 * |
-2.41
x | Employees | 18 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 30.92% |
Latest transcript on Ondine Biomedical Inc.
1 day | -9.68% | ||
1 week | -12.50% | ||
1 month | +30.23% | ||
3 months | -30.69% | ||
6 months | -15.15% | ||
Current year | -20.00% |
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 21-12-06 |
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7 | -9.68% | 80,025 |
24-05-30 | 7.75 | -.--% | 50,000 |
24-05-29 | 7.75 | -.--% | 281,292 |
24-05-28 | 7.75 | -3.12% | 267,191 |
24-05-24 | 8 | +6.67% | 85,242 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 24.7M | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- OBI Stock